Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03329677 · ClinicalTrials.gov registry record · NA
An 18-Month Psychotherapy of Borderline Personality Disorder
A NA study of Borderline Personality Disorder, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT03329677 is a NA study of Borderline Personality Disorder that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 61 participants, below the 104-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03329677, a NA study of Borderline Personality Disorder, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine the impact of an 18-month psychotherapy treatment for borderline personality disorder. The investigators will examine changes in psychosocial and work functioning in patients with borderline personality disorder using an 18-month psychotherapeutic treatment. The investigators are recruiting female patients between the ages of 18-35 who meet DSM criteria for BPD. The investigators are excluding patients who meet the following criteria: * psychotic disorders * a current major depressive episode * bipolar I disorder * current substance dependence * antisocial personality disorder. * unable to undergo 18-months of twice weekly psychotherapy in NYC (due to the COVID19 pandemic in person meetings are suspended (see detailed description) but will be restated once this is considered safe again) Participants in the study will receive 18-months of twice weekly psychotherapy, free of charge, as well as compensation for follow-up assessments. They may be currently taking psychiatric medication. Participants will be assessed using semi-structured diagnostic interviews, self-report instruments, and computerized tasks in an initial assessment session lasting about 6-8 hours. They will also be assessed using computerized tasks. Follow-up assessments will occur throughout the treatment as well as after the treatment, lasting about 1-4 hours. The investigators will also be collecting information on their treatment history and psychiatric medication as part of the study.
Conditions Studied
Interventions
- OTHER Transference-focused Psychotherapy (TFP)
Study Locations (1)
New York
- NewYork-Presbyterian/Weill Cornell Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2024-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03329677
The ClinicalTrials.gov registry entry for NCT03329677 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (41% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Borderline Personality Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transference-focused Psychotherapy (TFP) is the first listed.
NCT03329677 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03329677 about?
NCT03329677 is a clinical study titled "An 18-Month Psychotherapy of Borderline Personality Disorder". The purpose of the study is to examine the impact of an 18-month psychotherapy treatment for borderline personality disorder. The investigators will examine changes in psychosocial and work functioning in patients with borderline personality disorder using an 18-month psychotherapeutic treatment. T...
What is the current status of trial NCT03329677?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2016-01-01. Estimated completion is 2024-02-10.
What conditions does trial NCT03329677 study?
This clinical trial studies the following conditions: Borderline Personality Disorder.
What interventions are being tested in trial NCT03329677?
The interventions under investigation include: Transference-focused Psychotherapy (TFP) (OTHER).
Who is sponsoring clinical trial NCT03329677?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03329677 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Borderline Personality Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RECRUITING · NA
-
Cognitive Reappraisal Training for Borderline Personality (BPD)
RECRUITING · NA
-
Treatment of Borderline Personality Disorder With rTMS
RECRUITING · NA
-
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
RECRUITING · NA
-
PILOT Phase: BPD Study
ACTIVE NOT RECRUITING · NA
-
Neurofeedback for Borderline Personality Disorder
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.